New Data Available: Risk Factors for Placental Malaria, Mali, 2011-2019

Image of an African female doctor in a colofrul dress wearing a white N95 mask and holding up a foil pack of pills in her right hand.


Risk Factors for Placental Malaria, Sulfadoxine-pyrimethamine Doses, and Birth Outcomes in a Rural to Urban Prospective Cohort Study on the Bandiagara Escarpment and Bamako, Mali, 2011-2019 examines the issue of Mali having one of the highest incidence rates of malaria globally. The cohort is comprised of 249 women who, at the time of study enrollment, resided on the Bandiagara Escarpment. Placental samples and accompanying demographic data were collected, with the samples evaluated for malarial infection stage and parasite density. The study explores whether the risk for placental malaria was higher in urban Bamako or on the rural Escarpment, maternal risk factors, the association between preventative treatment doses, placental malaria, and birth outcomes, and finally what factors predicted the number of doses women received.

Funding is provided through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD/National Institutes of Health, the National Science Foundation, and the John Templeton Foundation.

Access the data here: Risk Factors for Placental Malaria, Sulfadoxine-pyrimethamine Doses, and Birth Outcomes in a Rural to Urban Prospective Cohort Study on the Bandiagara Escarpment and Bamako, Mali, 2011-2019

 

Jun 11, 2024

View other headlines